CapsoVision, Inc. (CV) Stock Analysis — Probabli.AI
AI-powered analysis for CV (CapsoVision, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $6.85 · Market cap: $356.8M · AI outlook: Bullish
CapsoVision appears to be positioned for substantial growth opportunities, bolstered by strategic partnerships, innovative developments, and healthtech market dynamics. While challenges such as the legal disputes exist, the overall positive momentum in the business environment suggests a net positive outlook.
Probabilistic 1-Year Outlook
- Bull 45% · Neutral 35% · Bear 20%
- 1-year price estimates — P10: $6 / P50: $10 / P90: $15
- CapsoVision has experienced a significant price drop recently, most likely attributed to market jitters or specific news. Despite this, the company has received consensus BUYS from analysts, and recent developments,…
5-Year Outlook
- Bull 50% · Neutral 30% · Bear 20%
- 5-year price estimates — P10: $6 / P50: $18 / P90: $33
SWOT Highlights
- Strength: Innovative product line in healthtech
- Strength: Strong industry partnerships
- Risk: Earnings sustainability is unclear
- Risk: High volatility and legal disputes create uncertainty
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
1 Wall Street analyst rate CV a BUY with a mean price target of $10.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
CV forecast details · CV sentiment details
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.